HEADER IMMUNE SYSTEM 23-SEP-20 7D4B TITLE CRYSTAL STRUCTURE OF 4-1BB IN COMPLEX WITH A VHH COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 9; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 4-1BB LIGAND RECEPTOR,CDW137,T-CELL ANTIGEN 4-1BB HOMOLOG,T- COMPND 5 CELL ANTIGEN ILA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ANTI-4-1BB VHH; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNFRSF9, CD137, ILA; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 10 ORGANISM_TAXID: 9844; SOURCE 11 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ANTIBODY, COMPLEX, VHH, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR C.WANG REVDAT 2 29-NOV-23 7D4B 1 REMARK REVDAT 1 14-JUL-21 7D4B 0 JRNL AUTH T.ZHAI,C.WANG,Y.XU,W.HUANG,Z.YUAN,T.WANG,S.DAI,S.PENG, JRNL AUTH 2 T.PANG,W.JIANG,Y.HUANG,Y.ZOU,Y.XU,J.SUN,X.GONG,J.ZHANG, JRNL AUTH 3 A.TSUN,B.LI,X.MIAO JRNL TITL GENERATION OF A SAFE AND EFFICACIOUS LLAMA SINGLE-DOMAIN JRNL TITL 2 ANTIBODY FRAGMENT (VHH) TARGETING THE MEMBRANE-PROXIMAL JRNL TITL 3 REGION OF 4-1BB FOR ENGINEERING THERAPEUTIC BISPECIFIC JRNL TITL 4 ANTIBODIES FOR CANCER. JRNL REF J IMMUNOTHER CANCER V. 9 2021 JRNL REFN ESSN 2051-1426 JRNL PMID 34172514 JRNL DOI 10.1136/JITC-2020-002131 REMARK 2 REMARK 2 RESOLUTION. 3.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 14654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 726 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.14 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.22 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1056 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.3900 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.5630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1994 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 146 REMARK 3 SOLVENT ATOMS : 7 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 90.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.12000 REMARK 3 B22 (A**2) : 4.12000 REMARK 3 B33 (A**2) : -8.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.409 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.318 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.250 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.886 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.916 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2229 ; 0.014 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 1948 ; 0.002 ; 0.018 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3028 ; 2.142 ; 1.739 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4535 ; 1.555 ; 1.662 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 268 ; 9.261 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 111 ;35.381 ;22.162 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 342 ;19.981 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;21.843 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 313 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2470 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 508 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7D4B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1300018717. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15429 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.140 REMARK 200 RESOLUTION RANGE LOW (A) : 47.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.90 REMARK 200 R MERGE (I) : 0.16200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 12.80 REMARK 200 R MERGE FOR SHELL (I) : 1.24100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6MGP, 4XTA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M LITHIUM SULFATE, 100 MM TRIS (PH REMARK 280 8.5), 10 MM NICKEL SULFATE, VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.20500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 53.42550 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 53.42550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.60250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 53.42550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 53.42550 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 109.80750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 53.42550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 53.42550 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.60250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 53.42550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 53.42550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 109.80750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.20500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 164 REMARK 465 GLY B 127 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY A 91 OD1 ASP A 105 1.30 REMARK 500 C GLY A 91 OD1 ASP A 105 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 28 30.04 -88.44 REMARK 500 ASN A 39 -63.43 -104.92 REMARK 500 ASN A 39 -111.45 -106.07 REMARK 500 ASN A 40 70.62 -44.21 REMARK 500 ASN A 40 10.16 -21.95 REMARK 500 ARG A 41 -107.10 134.99 REMARK 500 ARG A 75 -64.51 -94.94 REMARK 500 CYS A 99 65.38 60.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 40 ARG A 41 132.92 REMARK 500 REMARK 500 REMARK: NULL DBREF 7D4B A 25 162 UNP Q07011 TNR9_HUMAN 25 162 DBREF 7D4B B 1 127 PDB 7D4B 7D4B 1 127 SEQADV 7D4B LEU A 163 UNP Q07011 EXPRESSION TAG SEQADV 7D4B GLY A 164 UNP Q07011 EXPRESSION TAG SEQRES 1 A 140 GLN ASP PRO CYS SER ASN CYS PRO ALA GLY THR PHE CYS SEQRES 2 A 140 ASP ASN ASN ARG ASN GLN ILE CYS SER PRO CYS PRO PRO SEQRES 3 A 140 ASN SER PHE SER SER ALA GLY GLY GLN ARG THR CYS ASP SEQRES 4 A 140 ILE CYS ARG GLN CYS LYS GLY VAL PHE ARG THR ARG LYS SEQRES 5 A 140 GLU CYS SER SER THR SER ASN ALA GLU CYS ASP CYS THR SEQRES 6 A 140 PRO GLY PHE HIS CYS LEU GLY ALA GLY CYS SER MET CYS SEQRES 7 A 140 GLU GLN ASP CYS LYS GLN GLY GLN GLU LEU THR LYS LYS SEQRES 8 A 140 GLY CYS LYS ASP CYS CYS PHE GLY THR PHE ASN ASP GLN SEQRES 9 A 140 LYS ARG GLY ILE CYS ARG PRO TRP THR ASN CYS SER LEU SEQRES 10 A 140 ASP GLY LYS SER VAL LEU VAL ASN GLY THR LYS GLU ARG SEQRES 11 A 140 ASP VAL VAL CYS GLY PRO SER PRO LEU GLY SEQRES 1 B 127 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 B 127 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 127 SER THR PHE SER ILE VAL ALA MET GLY TRP TYR ARG GLN SEQRES 4 B 127 ALA PRO GLY LYS GLN ARG GLU LEU VAL ALA SER ILE ILE SEQRES 5 B 127 THR GLY ASP GLY ASP THR ASN TYR ALA ASP SER VAL LYS SEQRES 6 B 127 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 B 127 MET TYR LEU GLN MET ASN SER LEU LYS PRO GLU ASP THR SEQRES 8 B 127 ALA VAL TYR TYR CYS TYR ALA ARG THR GLY TYR GLY SER SEQRES 9 B 127 SER TRP LEU MET GLY HIS GLU TYR ASP TYR TRP GLY GLN SEQRES 10 B 127 GLY THR GLN VAL THR VAL SER SER LEU GLY HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET MAN C 6 11 HET FUC C 7 10 HET NAG D 1 14 HET NAG D 2 14 HET FUC D 3 10 HET CL A 201 1 HET CL A 202 1 HET SO4 A 203 5 HET SO4 A 204 5 HET CL B 201 1 HET EDO B 202 4 HET EDO B 203 4 HET SO4 B 204 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 3 MAN 3(C6 H12 O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 5 CL 3(CL 1-) FORMUL 7 SO4 3(O4 S 2-) FORMUL 10 EDO 2(C2 H6 O2) FORMUL 13 HOH *7(H2 O) HELIX 1 AA1 ASP A 26 ASN A 30 5 5 HELIX 2 AA2 CYS A 139 GLY A 143 5 5 HELIX 3 AA3 THR B 28 ILE B 31 5 4 HELIX 4 AA4 ASP B 62 LYS B 65 5 4 HELIX 5 AA5 LYS B 87 THR B 91 5 5 SHEET 1 AA1 2 THR A 35 CYS A 37 0 SHEET 2 AA1 2 CYS A 45 PRO A 47 -1 O SER A 46 N PHE A 36 SHEET 1 AA2 2 SER A 52 PHE A 53 0 SHEET 2 AA2 2 ASP A 63 ILE A 64 -1 O ASP A 63 N PHE A 53 SHEET 1 AA3 2 PHE A 72 LYS A 76 0 SHEET 2 AA3 2 GLU A 85 CYS A 88 -1 O GLU A 85 N ARG A 75 SHEET 1 AA4 2 PHE A 92 LEU A 95 0 SHEET 2 AA4 2 MET A 101 GLN A 104 -1 O GLU A 103 N HIS A 93 SHEET 1 AA5 2 GLN A 110 LEU A 112 0 SHEET 2 AA5 2 CYS A 117 ASP A 119 -1 O LYS A 118 N GLU A 111 SHEET 1 AA6 2 THR A 124 PHE A 125 0 SHEET 2 AA6 2 ARG A 134 PRO A 135 -1 O ARG A 134 N PHE A 125 SHEET 1 AA7 2 VAL A 146 VAL A 148 0 SHEET 2 AA7 2 VAL A 157 CYS A 158 -1 O VAL A 157 N LEU A 147 SHEET 1 AA8 4 VAL B 2 SER B 7 0 SHEET 2 AA8 4 LEU B 18 GLY B 26 -1 O ALA B 23 N VAL B 5 SHEET 3 AA8 4 THR B 78 MET B 83 -1 O MET B 83 N LEU B 18 SHEET 4 AA8 4 PHE B 68 ASP B 73 -1 N THR B 69 O GLN B 82 SHEET 1 AA9 6 GLY B 10 VAL B 11 0 SHEET 2 AA9 6 THR B 119 THR B 122 1 O THR B 122 N GLY B 10 SHEET 3 AA9 6 ALA B 92 ARG B 99 -1 N TYR B 94 O THR B 119 SHEET 4 AA9 6 ALA B 33 GLN B 39 -1 N TYR B 37 O TYR B 95 SHEET 5 AA9 6 ARG B 45 ILE B 52 -1 O ALA B 49 N TRP B 36 SHEET 6 AA9 6 THR B 58 TYR B 60 -1 O ASN B 59 N SER B 50 SHEET 1 AB1 4 GLY B 10 VAL B 11 0 SHEET 2 AB1 4 THR B 119 THR B 122 1 O THR B 122 N GLY B 10 SHEET 3 AB1 4 ALA B 92 ARG B 99 -1 N TYR B 94 O THR B 119 SHEET 4 AB1 4 ASP B 113 TRP B 115 -1 O TYR B 114 N ALA B 98 SSBOND 1 CYS A 28 CYS A 37 1555 1555 2.04 SSBOND 2 CYS A 31 CYS A 45 1555 1555 2.06 SSBOND 3 CYS A 48 CYS A 62 1555 1555 2.09 SSBOND 4 CYS A 65 CYS A 78 1555 1555 2.04 SSBOND 5 CYS A 68 CYS A 86 1555 1555 2.07 SSBOND 6 CYS A 88 CYS A 102 1555 1555 1.98 SSBOND 7 CYS A 94 CYS A 99 1555 1555 2.07 SSBOND 8 CYS A 106 CYS A 117 1555 1555 2.03 SSBOND 9 CYS A 120 CYS A 133 1555 1555 2.05 SSBOND 10 CYS A 139 CYS A 158 1555 1555 2.10 SSBOND 11 CYS B 22 CYS B 96 1555 1555 2.06 LINK ND2 ASN A 138 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN A 149 C1 NAG D 1 1555 1555 1.43 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.47 LINK O6 NAG C 1 C1 FUC C 7 1555 1555 1.45 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.46 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.44 LINK O3 BMA C 3 C1 MAN C 6 1555 1555 1.43 LINK O3 MAN C 4 C1 MAN C 5 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.46 LINK O6 NAG D 1 C1 FUC D 3 1555 1555 1.45 CRYST1 106.851 106.851 146.410 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009359 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009359 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006830 0.00000